These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 36661246)

  • 41. Follicular Fluid-Derived Exosomal MicroRNA-18b-5p Regulates PTEN-Mediated PI3K/Akt/mTOR Signaling Pathway to Inhibit Polycystic Ovary Syndrome Development.
    Zhou Z; Tu Z; Zhang J; Tan C; Shen X; Wan B; Li Y; Wang A; Zhao L; Hu J; Ma N; Zhou J; Chen L; Song Y; Lu W
    Mol Neurobiol; 2022 Apr; 59(4):2520-2531. PubMed ID: 35092573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of sitagliptin combined with rosiglitazone on autophagy and inflammation in polycystic ovary syndrome by regulating PI3K/AKT/mTOR and TLR4/NF-κB pathway.
    Ren Y; Ye Y; Xuan F; Chen A; Jin R; Zhou W; Lu J
    Reprod Biol; 2023 Jun; 23(2):100763. PubMed ID: 37075562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ficus deltoidea ameliorates biochemical, hormonal, and histomorphometric changes in letrozole-induced polycystic ovarian syndrome rats.
    Haslan MA; Samsulrizal N; Hashim N; Zin NSNM; Shirazi FH; Goh YM
    BMC Complement Med Ther; 2021 Nov; 21(1):291. PubMed ID: 34844580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth hormone activates PI3K/Akt signaling and inhibits ROS accumulation and apoptosis in granulosa cells of patients with polycystic ovary syndrome.
    Gong Y; Luo S; Fan P; Zhu H; Li Y; Huang W
    Reprod Biol Endocrinol; 2020 Dec; 18(1):121. PubMed ID: 33287836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis.
    Peng Q; Chen X; Liang X; Ouyang J; Wang Q; Ren S; Xie H; Wang C; Sun Y; Wu X; Liu H; Hei C; Sun M; Chang Q; Liu X; Li G; He R
    Front Endocrinol (Lausanne); 2023; 14():1070264. PubMed ID: 36755918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: Association with PI3K signaling pathway.
    Tong C; Wu Y; Zhang L; Yu Y
    Front Endocrinol (Lausanne); 2022; 13():1091147. PubMed ID: 36589825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic potentials of Quercetin in management of polycystic ovarian syndrome using Letrozole induced rat model: a histological and a biochemical study.
    Jahan S; Abid A; Khalid S; Afsar T; Qurat-Ul-Ain ; Shaheen G; Almajwal A; Razak S
    J Ovarian Res; 2018 Apr; 11(1):26. PubMed ID: 29615083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ocimum kilimandscharicum L. restores ovarian functions in letrozole - induced Polycystic Ovary Syndrome (PCOS) in rats: Comparison with metformin.
    Khaled N; El-Bahy AA; Radwan R; Handoussa H; AbdelMaksoud S
    Life Sci; 2019 Sep; 232():116640. PubMed ID: 31295470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of Acupuncture on Reproductive Endocrine and p-Akt Protein Expression in Polycystic Ovary Syndrome Rats with Insulin Resistance].
    Zhang Y; Cao S; Wen SD; Re ZC; Li YP; Tong L
    Zhen Ci Yan Jiu; 2018 Oct; 43(10):622-6. PubMed ID: 30365256
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of Therapeutic Effects of Erdosteine on Polycystic Ovary Syndrome in a Rat Model.
    Karateke A; Dokuyucu R; Dogan H; Ozgur T; Tas ZA; Tutuk O; Agturk G; Tumer C
    Med Princ Pract; 2018; 27(6):515-522. PubMed ID: 30293079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Repurposing new drug candidates and identifying crucial molecules underlying PCOS Pathogenesis Based On Bioinformatics Analysis.
    Dehghan Z; Mohammadi-Yeganeh S; Sameni M; Mirmotalebisohi SA; Zali H; Salehi M
    Daru; 2021 Dec; 29(2):353-366. PubMed ID: 34480296
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downregulated lncRNA HOTAIR ameliorates polycystic ovaries syndrome via IGF-1 mediated PI3K/Akt pathway.
    Chen C; Jiang X; Ding C; Sun X; Wan L; Wang C
    Gynecol Endocrinol; 2023 Jun; 39(1):2227280. PubMed ID: 37356454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High levels of fatty acid-binding protein 5 excessively enhances fatty acid synthesis and proliferation of granulosa cells in polycystic ovary syndrome.
    Liu J; Li J; Wu X; Zhang M; Yan G; Sun H; Li D
    J Ovarian Res; 2024 Feb; 17(1):44. PubMed ID: 38373971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Partially purified non-polar phytocomponents from Aloe barbadensis Mill. gel restores metabolic and reproductive comorbidities in letrozole-induced polycystic ovary syndrome rodent model- an "in-vivo" study.
    Dey A; Dhadhal S; Maharjan R; Nagar PS; Nampoothiri L
    J Ethnopharmacol; 2022 Jun; 291():115161. PubMed ID: 35271948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nasturtium officinale L. and metformin alleviate the estradiol- induced polycystic ovary syndrome with synergistic effects through modulation of Bax/Bcl-2/p53/caspase-3 signaling pathway and anti-inflammatory and anti-oxidative effects.
    Cui D; Xu Z; Qiu S; Sun Y
    J Food Biochem; 2022 Dec; 46(12):e14462. PubMed ID: 36351033
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Melatonin ameliorates ovarian dysfunction by regulating autophagy in PCOS via the PI3K-Akt pathway.
    Xie F; Zhang J; Zhai M; Liu Y; Hu H; Yu Z; Zhang J; Lin S; Liang D; Cao Y
    Reproduction; 2021 Jun; 162(1):73-82. PubMed ID: 33989172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cangfudaotan decoction inhibits mitochondria-dependent apoptosis of granulosa cells in rats with polycystic ovarian syndrome.
    Jiang XL; Tai H; Xiao XS; Zhang SY; Cui SC; Qi SB; Hu DD; Zhang LN; Kuang JS; Meng XS; Li SM
    Front Endocrinol (Lausanne); 2022; 13():962154. PubMed ID: 36465612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluating the therapeutic potential of moxibustion on polycystic ovary syndrome: a rat model study on gut microbiota and metabolite interaction.
    Lin Y; Zeng H; Lin J; Peng Y; Que X; Wang L; Chen L; Bai N
    Front Cell Infect Microbiol; 2024; 14():1328741. PubMed ID: 38665877
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Activation and significance of the PI3K/Akt pathway in endometrium with polycystic ovary syndrome patients].
    Zhang HY; Zhang YF; Han YK; Xue FX; Zhao XH; Zhang XL
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):19-23. PubMed ID: 22455688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.